Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Karen Takigami"'
Autor:
Hiroshi Matsuoka, Takahiro Hayashi, Karen Takigami, Kazuyoshi Imaizumi, Ryoichi Shiroki, Naoki Ohmiya, Kazumitsu Sugiura, Kenji Kawada, Akira Sawaki, Koutaro Maeda, Yousuke Ando, Ichiro Uyama
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) are used for the treatment of various cancer types. However, immune-related adverse events (irAEs) occur in patients treated with ICIs. Several s
Externí odkaz:
https://doaj.org/article/f2146f7cbe92496ba12c5d39c12cdd8b
Autor:
Ichiro Uyama, Kazuyoshi Imaizumi, Ryoichi Shiroki, Akira Sawaki, Naoki Ohmiya, Kazumitsu Sugiura, Yousuke Ando, Kenji Kawada, Karen Takigami, Koutaro Maeda, Hiroshi Matsuoka, Takahiro Hayashi
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Background Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 (PD-1) are used for the treatment of various cancer types. However, immune-related adverse events (irAEs) occur in patients treated with ICIs. Several small-scal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e865d996728c849b5555da91870996e8
https://pubmed.ncbi.nlm.nih.gov/32664888
https://pubmed.ncbi.nlm.nih.gov/32664888